A Healthy Dose of Data Science

Check out Tech Wire Asia podcast featuring Prospection's Co-CEO & Co-Founder, Eric Chung, as he discusses how Prospection is using global patient data to help guide critical, data-driven decision making about treatment efficacy, drug commercialisation, and patient outcomes for the life sciences companies. Eric shares his insights on the intricacies of using anonymised patient data, the external influences of healthcare models, and more.

Gathering medical data and using it to discover better treatments, more effective drugs and improved outcomes: all in a day’s work for Prospection’s Eric Chung.

Show notes for the podcast:

The medical data collected throughout our lives details who we are, what made us ill, and what treatments we’ve been given – and their outcomes. If we could give all that data to a smart set of algorithms, we can discover better treatments, more effective drugs and courses of action for when we, and others, are ill.

That’s the impetus behind and credo of Prospection. It’s a company that pieces together anonymized patient data, extrapolates results of treatments, and applies its findings to bring about more effective drugs and treatments.

Eric Chung started Prospection when he was bitten by the entrepreneurial bug, but his background is in data and artificial intelligence. Now, the company is a world leader in the very specific techniques and intricacies of using medical data for the betterment of treatments all over the world.

We chat about how patient data is different depending on where it comes from, the external influences of healthcare models, anonymization and more.

Listen to the podcast here: https://techwireasia.com/podcast-series/medical-data-best-uses-of-hospital-research-best-podcast/

Our Products

Our data and insights tools were built specifically for the industry, bringing advanced analytics, statistical modelling and machine learning to longitudinal healthcare data.